Precigen (PGEN) Short-Term Debt repayments (2014 - 2022)
Precigen (PGEN) reported Short-Term Debt repayments of -$115.7 million for Q4 2022, down 4741.17% quarter-over-quarter from $2.5 million in Q2 2020.
Precigen (PGEN) Short-Term Debt repayments (2014 - 2022) Analysis & Trends
Precigen (PGEN) has 8 years of Short-Term Debt repayments data on file, last reported at -$115.7 million in Q4 2022.
- Short-Term Debt repayments for Q4 2022 came in at -$115.7 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was -$115.7 million (changed N/A YoY), and the FY2020 annual result was $11.9 million, up 15.78% from the prior year.
- Short-Term Debt repayments slipped to -$115.7 million in Q4 2022 per PGEN's latest filing, from $2.5 million in the prior quarter.
- Over five years, Short-Term Debt repayments peaked at $9.4 million in Q1 2020 and troughed at -$115.7 million in Q4 2022.
- A 4-year average of -$8.1 million and a median of $1.3 million in 2018 frame the typical range for Short-Term Debt repayments.
- The sharpest annual moves came in 2018 and 2020: Short-Term Debt repayments sank 55.62% in 2018, then surged 490.8% in 2020.
- A 4-year view of Short-Term Debt repayments shows it stood at $1.1 million in 2018, then soared by 443.33% to $5.8 million in 2019, then plunged by 56.89% to $2.5 million in 2020, then slumped by 4741.17% to -$115.7 million in 2022.
- Business Quant data shows PGEN's Short-Term Debt repayments at -$115.7 million in Q4 2022, $2.5 million in Q2 2020, and $9.4 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 102,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -482,347.21 |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -115.66 Mn |
| Dec 31, 2022 | -115.66 Mn |
| Jun 30, 2020 | 2.49 Mn |
| Jun 30, 2020 | 2.49 Mn |
| Mar 31, 2020 | 9.44 Mn |
| Mar 31, 2020 | 9.44 Mn |
| Dec 31, 2019 | 5.78 Mn |
| Dec 31, 2019 | 5.78 Mn |
| Sep 30, 2019 | 1.19 Mn |
| Sep 30, 2019 | 1.19 Mn |
| Jun 30, 2019 | 1.73 Mn |
| Jun 30, 2019 | 1.73 Mn |
| Mar 31, 2019 | 1.60 Mn |
| Mar 31, 2019 | 1.60 Mn |
| Dec 31, 2018 | 1.06 Mn |
| Dec 31, 2018 | 1.06 Mn |
| Sep 30, 2018 | 1.33 Mn |
| Sep 30, 2018 | 1.33 Mn |
| Jun 30, 2018 | 786,000.00 |
| Jun 30, 2018 | 786,000.00 |